113 related articles for article (PubMed ID: 22151745)
21. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
Soyka M
Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
[TBL] [Abstract][Full Text] [Related]
22. Psychotic experiences in the general population: a twenty-year prospective community study.
Rössler W; Riecher-Rössler A; Angst J; Murray R; Gamma A; Eich D; van Os J; Gross VA
Schizophr Res; 2007 May; 92(1-3):1-14. PubMed ID: 17363221
[TBL] [Abstract][Full Text] [Related]
23. Predictors of cannabis use in men with and without psychosis.
Green B; Kavanagh DJ; Young RM
Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
[TBL] [Abstract][Full Text] [Related]
24. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
25. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
26. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
[TBL] [Abstract][Full Text] [Related]
27. [Inhalant abusers and psychiatric symptoms].
Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
[TBL] [Abstract][Full Text] [Related]
28. Substance misuse at presentation to an early psychosis program.
Van Mastrigt S; Addington J; Addington D
Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
[TBL] [Abstract][Full Text] [Related]
29. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
Latt N; Jurd S; Tennant C; Lewis J; Macken L; Joseph A; Grochulski A; Long L
Australas Psychiatry; 2011 Aug; 19(4):354-9. PubMed ID: 21851228
[TBL] [Abstract][Full Text] [Related]
30. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
[TBL] [Abstract][Full Text] [Related]
31. Effect of substance misuse in early psychosis.
Addington J; Addington D
Br J Psychiatry Suppl; 1998; 172(33):134-6. PubMed ID: 9764140
[TBL] [Abstract][Full Text] [Related]
32. [Cannabis and psychoses].
Kristensen FW
Ugeskr Laeger; 1994 May; 156(19):2875-8, 2881. PubMed ID: 8009723
[TBL] [Abstract][Full Text] [Related]
33. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
34. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.
Addington J; Addington D
Acta Psychiatr Scand; 2007 Apr; 115(4):304-9. PubMed ID: 17355521
[TBL] [Abstract][Full Text] [Related]
35. Illicit substance use and its correlates in first episode psychosis.
Mazzoncini R; Donoghue K; Hart J; Morgan C; Doody GA; Dazzan P; Jones PB; Morgan K; Murray RM; Fearon P
Acta Psychiatr Scand; 2010 May; 121(5):351-8. PubMed ID: 19824986
[TBL] [Abstract][Full Text] [Related]
36. Drugs of abuse and increased risk of psychosis development.
Gururajan A; Manning EE; Klug M; van den Buuse M
Aust N Z J Psychiatry; 2012 Dec; 46(12):1120-35. PubMed ID: 22833579
[TBL] [Abstract][Full Text] [Related]
37. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
Barkus E; Lewis S
Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
[TBL] [Abstract][Full Text] [Related]
38. Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.
Murrie B; Lappin J; Large M; Sara G
Schizophr Bull; 2020 Apr; 46(3):505-516. PubMed ID: 31618428
[TBL] [Abstract][Full Text] [Related]
39. Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland.
Rössler W; Ajdacic-Gross V; Haker H; Rodgers S; Müller M; Hengartner MP
Epidemiol Psychiatr Sci; 2015 Feb; 24(1):69-77. PubMed ID: 24280150
[TBL] [Abstract][Full Text] [Related]
40. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County.
Allebeck P; Adamsson C; Engström A; Rydberg U
Acta Psychiatr Scand; 1993 Jul; 88(1):21-4. PubMed ID: 8372691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
